Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anaptysbio (ANAB) Non-Current Debt (2016 - 2018)

Anaptysbio's Non-Current Debt history spans 3 years, with the latest figure at $625000.0 for Q4 2018.

  • For Q4 2018, Non-Current Debt fell 91.73% year-over-year to $625000.0; the TTM value through Dec 2018 reached $625000.0, down 91.73%, while the annual FY2018 figure was $625000.0, 91.73% down from the prior year.
  • Non-Current Debt reached $625000.0 in Q4 2018 per ANAB's latest filing, down from $2.4 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $13.8 million in Q4 2016 to a low of $625000.0 in Q4 2018.
  • Average Non-Current Debt over 3 years is $7.5 million, with a median of $7.6 million recorded in 2017.
  • Peak YoY movement for Non-Current Debt: tumbled 45.3% in 2017, then plummeted 91.73% in 2018.
  • A 3-year view of Non-Current Debt shows it stood at $13.8 million in 2016, then crashed by 45.3% to $7.6 million in 2017, then tumbled by 91.73% to $625000.0 in 2018.
  • Per Business Quant, the three most recent readings for ANAB's Non-Current Debt are $625000.0 (Q4 2018), $2.4 million (Q3 2018), and $4.1 million (Q2 2018).